We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTB
301
Connect Biopharma Holdings
CNTB
$138M
$725K 0.02%
510,701
– –
IRON icon
302
Disc Medicine
IRON
$2.97B
$722K 0.02%
14,683
+1,364
+10% +$64K
MRVL icon
303
Marvell Technology
MRVL
$189B
$721K 0.02%
10,000
-90,000
-90% -$6.22M
VKTX icon
304
Viking Therapeutics
VKTX
$3.88B
$716K 0.02%
+11,316
New +$664K
THRD
305
DELISTED
Third Harmonic Bio
THRD
$709K 0.02%
52,294
+3,043
+6% +$37.7K
SPKL
306
Spark I Acquisition Corp
SPKL
$101M
$702K 0.02%
66,832
-2,159
-3% -$22.5K
DYN icon
307
Dyne Therapeutics
DYN
$4.83B
$694K 0.02%
19,318
-13,626
-41% -$542K
DRH icon
308
Diamondrock Hospitality Co
DRH
$2.59B
$690K 0.02%
+79,007
New +$665K
ZS icon
309
Zscaler
ZS
$26.3B
$684K 0.02%
+4,000
New +$731K
ARVN icon
310
Arvinas
ARVN
$568M
$675K 0.02%
27,403
-2,898
-10% -$75.7K
ITOS
311
DELISTED
iTeos Therapeutics
ITOS
$673K 0.02%
65,940
+30,617
+87% +$467K
NFE icon
312
PUT
New Fortress Energy
NFE
$98M
$659K 0.02%
51,100
– –
VRNA
313
DELISTED
Verona Pharma
VRNA
$649K 0.02%
+22,541
New +$555K
SKIL icon
314
Skillsoft
SKIL
$72.1M
$646K 0.02%
41,692
– –
MIRM icon
315
Mirum Pharmaceuticals
MIRM
$5.74B
$645K 0.02%
16,538
-21,550
-57% -$860K
XNCR icon
316
Xencor
XNCR
$1.49B
$644K 0.02%
+32,000
New +$601K
XRX icon
317
PUT
Xerox
XRX
$424M
$623K 0.02%
278,300
– –
NARI
318
DELISTED
Inari Medical, Inc. Common Stock
NARI
$623K 0.02%
+15,100
New +$725K
NLY icon
319
Annaly Capital Management
NLY
$17.1B
$614K 0.02%
+30,591
New +$613K
AFRM icon
320
Affirm
AFRM
$25.6B
$612K 0.02%
15,000
+500
+3% +$16.6K
COTY icon
321
PUT
Coty
COTY
$2.39B
$606K 0.02%
1,264,500
– –
PCVX icon
322
Vaxcyte
PCVX
$8.76B
$606K 0.02%
5,307
-1,000
-16% -$90.1K
CNTX icon
323
Context Therapeutics
CNTX
$46.3M
$605K 0.01%
308,758
+15,000
+5% +$33.3K
QTTB icon
324
Q32 Bio
QTTB
$482M
$590K 0.01%
13,229
+1,229
+10% +$45.2K
ALGS icon
325
Aligos Therapeutics
ALGS
$34.1M
$581K 0.01%
67,096
+27,096
+68% +$337K
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.